CEVAC at Ghent University Hospital/Ghent University supports the clinical development of safe and effective vaccines. The Clinical Trial Unit ensures reliable, high-quality enrolment and execution of Phase I–III studies, while the Immunomonitoring Laboratory evaluates antibody and T-cell responses to provide robust data guiding next-generation vaccine development.
Join our mailing list to receive exclusive content and offers.